Transaction Valuation* | Amount of Filing Fee** | |
$212,565,362
|
$25,018.94 | |
* | The transaction valuation was calculated by adding (i) the number of all outstanding shares of common stock of D & K Healthcare Resources, Inc. (14,260,856 shares) multiplied by a purchase price of $14.50 per share and (ii) the number of options to purchase shares of common stock of D & K Healthcare Resources Inc. with exercise prices at or below $14.50 per share (options to purchase 774,066 shares) multiplied by the difference between (A) $14.50 per share and (B) the weighted average exercise price per share ($7.03) of such options. |
** | The filing fee was calculated pursuant to Rule 0-11 under the Securities Exchange Act of 1934, as amended, and was determined by multiplying 0.00011770 by the sum of (i) the number of all outstanding shares of common stock of D & K Healthcare Resources, Inc. (14,260,856 shares) multiplied by a purchase price of $14.50 per share and (ii) the number of options to purchase shares of common stock of D & K Healthcare Resources Inc. with exercise prices at or below $14.50 per share (options to purchase 774,066 shares) multiplied by the difference between (A) $14.50 per share and (B) the weighted average exercise price per share ($7.03) of such options. |
o | Check the box if any part of the fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number or the Form or Schedule and the date of its filing. |
Amount Previously Paid: N/A
|
Form or Registration No. N/A | |
Filing party: N/A
|
Date Filed: N/A |
o | Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
Check the appropriate boxes below to designate any transactions to which the statement relates: |
þ | third-party tender offer subject to Rule 14d-1. |
o | issuer tender offer subject to Rule 13e-4. |
o | going-private transaction subject to Rule 13e-3. |
o | amendment to Schedule 13D under Rule 13d-2. |
Check the following box if the filing is a final amendment reporting the results of the tender offer: o |
(a)(1)(A)
|
Offer to Purchase, dated July 22, 2005. | |
(a)(1)(B)
|
Form of Letter of Transmittal. | |
(a)(1)(C)
|
Form of Notice of Guaranteed Delivery. | |
(a)(1)(D)
|
Form of Letter to Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees. | |
(a)(1)(E)
|
Form of Letter to Clients for use by Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees. | |
(a)(1)(F)
|
Guidelines for Certification of Taxpayer Identification Number on Substitute Form W-9. | |
(a)(1)(G)
|
Press Release issued by McKesson Corporation on July 11, 2005, incorporated herein by reference to Form 8-K previously filed with the Securities and Exchange Commission. | |
(a)(1)(H)
|
Press Release issued by McKesson Corporation on July 22, 2005. | |
(a)(5)
|
Summary Advertisement, dated July 22, 2005, appearing in The Wall Street Journal. | |
(d)(1)
|
Agreement and Plan of Merger, dated as of July 8, 2005, by and among McKesson Corporation, Spirit Acquisition Corporation and D & K Healthcare Resources, Inc. | |
(d)(2)
|
Stockholder Support Agreement, dated as of July 8, 2005, among McKesson Corporation, Spirit Acquisition Corporation and certain shareholders of D & K Healthcare Resources, Inc. that are listed on Schedule I attached thereto. | |
(d)(3)
|
Confidentiality Agreement, dated as of March 24, 2005, between McKesson Corporation and D & K Healthcare Resources, Inc. |
Spirit Acquisition Corporation | ||||
By: |
/s/ Nicholas A. Loiacono --------------------------------------------- Name: Nicholas A. Loiacono Title: Vice President and Treasurer |
|||
McKesson Corporation | ||||
By: |
/s/ Ivan D. Meyerson --------------------------------------------- Name: Ivan D. Meyerson Title: Executive Vice President, General Counsel and Secretary |
Exhibit No. | Exhibit Name | |||||
(a)(1)(A) | Offer to Purchase, dated July 22, 2005. | |||||
(a)(1)(B) | Form of Letter of Transmittal. | |||||
(a)(1)(C) | Form of Notice of Guaranteed Delivery. | |||||
(a)(1)(D) | Form of Letter to Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees. | |||||
(a)(1)(E) | Form of Letter to Clients for use by Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees. | |||||
(a)(1)(F) | Guidelines for Certification of Taxpayer Identification Number on Substitute Form W-9. | |||||
(a)(1)(G) | Press Release issued by McKesson Corporation on July 11, 2005, incorporated herein by reference to Form 8-K previously filed with the Securities and Exchange Commission. | |||||
(a)(1)(H) | Press Release issued by McKesson Corporation on July 22, 2005. | |||||
(a)(5) | Summary Advertisement, dated July 22, 2005, appearing in The Wall Street Journal. | |||||
(d)(1) | Agreement and Plan of Merger, dated as of July 8, 2005, by and among McKesson Corporation, Spirit Acquisition Corporation and D & K Healthcare Resources, Inc. | |||||
(d)(2) | Stockholder Support Agreement, dated as of July 8, 2005, among McKesson Corporation, Spirit Acquisition Corporation and certain shareholders of D & K Healthcare Resources, Inc. that are listed on Schedule I attached thereto. | |||||
(d)(3) | Confidentiality Agreement, dated as of March 24, 2005, between McKesson Corporation and D & K Healthcare Resources, Inc. |